Skip to main content
SpringerLink
Log in

Methodological aspects of randomized controlled trials on cognitive interventions

  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

The aims of this article were to assess the methodological challenges of randomized controlled trials (RCTs) on cognitive interventions for people with multiple sclerosis, and to discuss specific problems related to rehabilitation trials. A bibliographic search was carried out. Selected articles were examined using five methodological quality criteria related to description of the target population, method of allocation, masking of patient and examiner, the outcome measures and analysis. A total of 12 RCTs, published between 1996 and 2010, were found. Five RCTs were on drug therapy (two on disease-modifying therapies, one on donepezil and two on drugs for fatigue). Seven RCTs were on rehabilitation (six on PC-based retraining techniques). The quality of the studies was overall low, inadequate selection of the target population and limited study size being the most frequent limitations. No clear improvement was found in the most recent studies. Additional methodological problems specific to rehabilitation trials are difficulties in defining and reproducing the study intervention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Verhagen AP, de-Vet HCW, de-Bie RA et al (1998) The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 51:1235–1241

    Article  CAS  PubMed  Google Scholar 

  2. Weinstein A, Schwid SIL, Schiffer RB et al (1999) Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch Neurol 56:319–324

    Article  CAS  PubMed  Google Scholar 

  3. Fischer JS, Priore RL, Jacobs LD et al (2000) Neuropsychological effects of interferon B-1a in relapsing multiple sclerosis. Ann Neurol 48:885–892

    Article  CAS  PubMed  Google Scholar 

  4. Smits RC, Emmen HH, Bertlesmann FW et al (1994) The effects of 4-aminopyridine on cognitive function in patients with multiple sclerosis. Neurology 44:1701–1705

    CAS  PubMed  Google Scholar 

  5. Geisler MW, Sliwinski M, Coyle PK et al (1996) The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis. Arch Neurol 53:185–188

    CAS  PubMed  Google Scholar 

  6. Krupp LB, Christdoulou C, Melville RN et al (2004) Donepezil improved memory in multiple sclerosis in a randomized controlled trial. Neurology 63:1579–1585

    CAS  PubMed  Google Scholar 

  7. Jønsson A, Korfitzen EM, Heltberg A et al (1993) Effect of neuropsychological treatment in patients with multiple sclerosis. Acta Neurol Scand 88:394–400

    Article  PubMed  Google Scholar 

  8. Mendozzi L, Pugnetti L, Motta A et al (1998) Computer-assisted memory retraining of patients with multiple sclerosis. Neurol Sci 19:S431–S438

    Google Scholar 

  9. Lincoln NB, Dent A, Harding J et al (2002) Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J Neurol Neurosurg Psychiatry 72:93–98

    Article  CAS  PubMed  Google Scholar 

  10. Solari A, Motta A, Mendozzi L et al (2004) Computer-aided retraining of memory and attention in people with multiple sclerosis: a randomized, double-blind controlled trial. J Neurol Sci 222:99–104

    Article  PubMed  Google Scholar 

  11. Chiaravalloti ND, DeLuca J, Moore NB, Ricker JH (2005) Treating learning impairments improves memory performance in multiple sclerosis: a randomized clinical trial. Mult Scler 11:58–68

    Article  PubMed  Google Scholar 

  12. Hildebrandt H, Lanz M, Hahn HK et al (2007) Cognitive training in MS: effects and relation to brain atrophy. Restor Neurol Neurosci 25:33–43

    PubMed  Google Scholar 

  13. Mattioli F, Stampatori C, Zanotti D et al (2010) Efficacy and specificity of intensive cognitive rehabilitation of attention and executive functions in multiple sclerosis. J Neurol Sci 288:101–105

    Article  Google Scholar 

  14. Kenneth F, Schulz KF, Altman DG, Moher D, for the CONSORT Group (2010) CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332

    Article  Google Scholar 

  15. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, for the CONSORT Group (2008) Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 148:295–309

    PubMed  Google Scholar 

  16. Medical Research Council (2000) A framework for development and evaluation of RCTs for complex interventions to improve health. Medical Research Council, London

    Google Scholar 

  17. Medical Research Council (2008) Developing and evaluating complex interventions: new guidance. Medical Research Council, London

    Google Scholar 

Download references

Conflict of interest statement

The author declares that she has no conflict of interests related to the publication of this article.

Author information

Authors and Affiliations

  1. Unit of Neuroepidemiology, Foundation IRCCS Neurological Institute C. Besta, Via Celoria, 11, 20133, Milan, Italy

    Alessandra Solari

Authors
  1. Alessandra Solari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandra Solari.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Solari, A. Methodological aspects of randomized controlled trials on cognitive interventions. Neurol Sci 31 (Suppl 2), 279–282 (2010). https://doi.org/10.1007/s10072-010-0375-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-010-0375-5

Keywords

Search

Navigation